Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
Your donations help support people living with type 1 diabetes today and fund the best treatment and cure research, no matter where in the world it takes place.
You could win a cash prize of up to £25,000 when you play the JDRF lottery. As well as the chance to win great prizes, you'll also help fund our research to find a cure for type 1 diabetes.
The announcement is the biggest treatment breakthrough for type 1 diabetes since the discovery of insulin.
Join us on Saturday 21 September 2024 with hundreds of JDRF supporters celebrating One Walk Belfast!
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
JDRF is undergoing a transformation.We are becoming Breakthrough T1D in October.
Home > For professionals > Policymakers > Reports and resources
A joint partnership programme building awareness of and access to type 1 diabetes technology choices.
Findings from JDRF's market research that will enable us to explore the types of support and interventions we can develop to help people living with type 1 diabetes choose the best possible treatments.
Confronting the unequal access to type 1 diabetes healthcare, JDRF’s Covid and Beyond report reveals the impact of the Covid pandemic upon lives already affected by type 1 diabetes.
Are You #AutoimmuneAware? from Connect Immune Research reveals the increase in autoimmune conditions and highlights the need for greater recognition and investment for autoimmunity as a distinct research area.
This report sets out a new way of approaching type 1 diabetes within the UK’s Research and Development landscape, and centres the voice of people living with the condition. It identifies some of the challenges facing the progress towards pioneering new treatments and cures and highlights opportunities for accelerating access to new treatments and technologies.
Published by the IPPR.
